Open original FDA record ↗Recall record
- FDA identifier
- Z-3080-2026
- Company in FDA record
- BD SWITZERLAND SARL
- FDA classification date
- Sep 15, 2026
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class I
Reason stated in the source
Due to discrepancies in specific attributes in the performance data for infusion sets, which may lead to inappropriate pump performance.
Source facts
- Action
- On 08/19/2026, an "URGENT MEDICAL DEVICE CORRECTION" letter was sent via FedEx and other courier services informing customers that, the BD Alaris" Pump Module Model 8100, when used with some BD Alaris" Pump Infusion Sets at low flow rates or to deliver low bolus volumes, may perform worse than previously disclosed. Due to the difficulty in recognizing these performance issues, users may fail to identify them as the cause of clinically significant changes in a patient's condition. Performance attributes that differ from previously communicated values have the potential to result in greater degrees of under / overinfusion, delayed time to occlusion alarms, and bolus dose inaccuracies. The Recall Notificaiton provides Clinical Recommendations for Sets with Updated Performance. Customers are instructed to: Immediately discard any sets listed within Attachment C: Discontinued Alaris" Pump Sets per your facility s procedures. a. To receive credit for discarded product, please return the completed Customer Response Form attached to this notice. If a set is included on Attachment C as discontinued, identify an alternate BD Alaris" Pump infusion set that is clinically appropriate and specific to the use case. If alternate sets are limited in quantity, they should be prioritized for use in critical-care, neonatal, infant, and pediatric care areas. 1. Review Attachments A, B, C and D and make any necessary adjustments to clinical use or set selection. Forward this communication to all areas of the facility where sets are being used. 2. Complete the attached Customer Response Form and return to the BD contact noted on the form whether or not you have any of the impacted material so that BD may acknowledge your receipt of this notification. For questions or assistance- contact BD Technical Support at 866-488-1408 Phone hours: 5:00 am to 5:00 pm PT Monday Friday Create a case at: https://bd.com/self-service or Alarismedicalaffairs@bd.com for clinical questions.
- Initiated
- 2026-08-19
- Root cause
- Device Design
- Distribution
- U.S.: Nation-wide - AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, GU, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MP, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, PR, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV, and WY. O.U.S.: Australia Belgium Bahrain Botswana Canada Cuba China France Germany Gibraltar Israel India Italy Japan Korea, Republic of Kuwait Mexico Malaysia Netherlands New Zealand Philippines Pakistan Qatar Saudi Arabia Singapore South Africa Switzerland Taiwan, Province of China Turkey United Arab Emirates United Kingdom
- Recall number
- Z-3080-2026
- Recall status
- Open, Classified
- CDRH record ID
- 221227
- FDA classified
- 2026-09-15
- Recall event number
- 99298